Kurt A Freeman1, Erin Olufs, Megan Tudor, Jean-Baptiste Roullet, Robert D Steiner. 1. *Division of Psychology, Institute on Development and Disability, Oregon Health & Science University, Portland, OR; †Department of Pediatrics, Oregon Health & Science University, Portland, OR; ‡Child Study Center, Yale School of Medicine, New Haven, CT; §Experimental and Systems Pharmacology, Washington State University, Spokane, WA; ‖University of Wisconsin School of Medicine and Public Health, Madison, WI.
Abstract
OBJECTIVE: Smith-Lemli-Opitz syndrome (SLOS) is a rare genetic disorder characterized by cholesterol synthesis impairment. A host of physical, developmental, and behavioral presentations are associated with SLOS, many of which have been related with disorder severity. Sleep disturbance is commonly reported in SLOS. This study is the first to examine the association between sleep disturbance and biomarkers of cholesterol synthesis defect. METHOD: Twenty youth with SLOS participated. Biomarkers of cholesterol synthesis were obtained, including plasma sterols (i.e., 7-dehydrocholesterol, 8-dehydrocholesterol, and cholesterol), mevalonic acid, and 24-S hydroxycholsterol. A ratio of plasma cholesterol precursors to cholesterol levels was used as a measure of biochemical severity. Parents reported their children's sleep problems using the Children's Sleep Habits Questionnaire. RESULTS: Most markers of cholesterol synthesis disruption were associated with overall sleep disturbance. Biochemical severity of SLOS was also associated with specific sleep problems (e.g., decreased sleep duration and increased sleep onset delay) and was identified as a significant predictor of these factors. CONCLUSION: This study is the first to demonstrate associative relationships between cholesterol levels and sleep disturbance in youth with SLOS. These results add to the current understanding of how cholesterol levels may contribute to the behavioral phenotype of SLOS. These findings may inform future studies related to the role cholesterol synthesis defects play in the behavioral phenotype of SLOS and, subsequently, modalities of intervention for behavioral symptoms.
OBJECTIVE:Smith-Lemli-Opitz syndrome (SLOS) is a rare genetic disorder characterized by cholesterol synthesis impairment. A host of physical, developmental, and behavioral presentations are associated with SLOS, many of which have been related with disorder severity. Sleep disturbance is commonly reported in SLOS. This study is the first to examine the association between sleep disturbance and biomarkers of cholesterol synthesis defect. METHOD: Twenty youth with SLOS participated. Biomarkers of cholesterol synthesis were obtained, including plasma sterols (i.e., 7-dehydrocholesterol, 8-dehydrocholesterol, and cholesterol), mevalonic acid, and 24-S hydroxycholsterol. A ratio of plasma cholesterol precursors to cholesterol levels was used as a measure of biochemical severity. Parents reported their children's sleep problems using the Children's Sleep Habits Questionnaire. RESULTS: Most markers of cholesterol synthesis disruption were associated with overall sleep disturbance. Biochemical severity of SLOS was also associated with specific sleep problems (e.g., decreased sleep duration and increased sleep onset delay) and was identified as a significant predictor of these factors. CONCLUSION: This study is the first to demonstrate associative relationships between cholesterol levels and sleep disturbance in youth with SLOS. These results add to the current understanding of how cholesterol levels may contribute to the behavioral phenotype of SLOS. These findings may inform future studies related to the role cholesterol synthesis defects play in the behavioral phenotype of SLOS and, subsequently, modalities of intervention for behavioral symptoms.
Authors: Jean-Baptiste Roullet; Louise S Merkens; Anuradha S Pappu; Megan D Jacobs; Rolf Winter; William E Connor; Robert D Steiner Journal: J Inherit Metab Dis Date: 2012-03-06 Impact factor: 4.982
Authors: Kurt A Freeman; Rose Eagle; Louise S Merkens; Darryn Sikora; Kersti Pettit-Kekel; Mina Nguyen-Driver; Robert D Steiner Journal: Cogn Behav Neurol Date: 2013-03 Impact factor: 1.600
Authors: D Haas; S F Garbade; C Vohwinkel; N Muschol; F K Trefz; J M Penzien; J Zschocke; G F Hoffmann; P Burgard Journal: J Inherit Metab Dis Date: 2007-05-11 Impact factor: 4.982
Authors: Mark J Merkens; Nancy L Sinden; Christine D Brown; Louise S Merkens; Jean-Baptiste Roullet; Thuan Nguyen; Robert D Steiner Journal: J Pediatr Date: 2014-07-16 Impact factor: 4.406
Authors: Katalin Koczok; László Horváth; Zeljka Korade; Zoltán András Mezei; Gabriella P Szabó; Ned A Porter; Eszter Kovács; Károly Mirnics; István Balogh Journal: Biomolecules Date: 2021-08-17